| abstract |
An ophthalmic composition of the present invention comprises cetirizine, a pharmaceutically acceptable salt thereof, and/or an optical isomer thereof, as active ingredients, and comprises tocofersolan. Therefore, the ophthalmic composition of the present invention can achieve delayed release of the active ingredients, and achieve excellent stability and sensation when applied as an eye drop. |